These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
115 related articles for article (PubMed ID: 3712039)
1. No-carrier-added fluorine-18-labeled N-methylspiroperidol: synthesis and biodistribution in mice. Shiue CY; Fowler JS; Wolf AP; McPherson DW; Arnett CD; Zecca L J Nucl Med; 1986 Feb; 27(2):226-34. PubMed ID: 3712039 [TBL] [Abstract][Full Text] [Related]
2. (3-N-[11C]methyl)spiperone, a ligand binding to dopamine receptors: radiochemical synthesis and biodistribution studies in mice. Burns HD; Dannals RF; Langström B; Ravert HT; Zemyan SE; Duelfer T; Wong DF; Frost JJ; Kuhar MJ; Wagner HN J Nucl Med; 1984 Nov; 25(11):1222-7. PubMed ID: 6333496 [TBL] [Abstract][Full Text] [Related]
3. Fluorine-18-N-methylspiroperidol: radiolytic decomposition as a consequence of high specific activity and high dose levels. MacGregor RR; Schlyer DJ; Fowler JS; Wolf AP; Shiue CY J Nucl Med; 1987 Jan; 28(1):60-7. PubMed ID: 3491887 [TBL] [Abstract][Full Text] [Related]
4. Syntheses and specific activity determinations of no-carrier-added (NCA) F-18-labeled butyrophenone neuroleptics--benperidol, haloperidol, spiroperidol, and pipamperone. Shiue CY; Fowler JS; Wolf AP; Watanabe M; Arnett CD J Nucl Med; 1985 Feb; 26(2):181-6. PubMed ID: 2857191 [TBL] [Abstract][Full Text] [Related]
5. [18F]-N-Methylspiroperidol: the radioligand of choice for PETT studies of the dopamine receptor in human brain. Arnett CD; Fowler JS; Wolf AP; Shiue CY; McPherson DW Life Sci; 1985 Apr; 36(14):1359-66. PubMed ID: 3872397 [TBL] [Abstract][Full Text] [Related]
6. Carrier-added and no-carrier-added syntheses of [18F]spiroperidol and [18F]haloperidol. Kilbourn MR; Welch MJ; Dence CS; Tewson TJ; Saji H; Maeda M Int J Appl Radiat Isot; 1984 Jul; 35(7):591-8. PubMed ID: 6469389 [TBL] [Abstract][Full Text] [Related]
7. A direct comparison of the brain uptake and plasma clearance of N-[11C]methylspiroperidol and [18F]N-methylspiroperidol in baboon using PET. Fowler JS; Arnett CD; Wolf AP; Shiue CY; MacGregor RR; Halldin C; Långström B; Wagner HN Int J Rad Appl Instrum B; 1986; 13(3):281-4. PubMed ID: 3771261 [TBL] [Abstract][Full Text] [Related]
8. No-carrier-added N-(3-[18F]fluoropropyl)spiroperidol: biodistribution in mice and tomographic studies in a baboon. Shiue CY; Bai LQ; Teng RR; Arnett CD; Wolf AP J Nucl Med; 1987 Jul; 28(7):1164-70. PubMed ID: 3496434 [TBL] [Abstract][Full Text] [Related]
9. Improved delineation of human dopamine receptors using [18F]-N-methylspiroperidol and PET. Arnett CD; Wolf AP; Shiue CY; Fowler JS; MacGregor RR; Christman DR; Smith MR J Nucl Med; 1986 Dec; 27(12):1878-82. PubMed ID: 3491193 [TBL] [Abstract][Full Text] [Related]
10. Synthesis of N-methyl and N-11C-methyl spiperone by phase transfer catalysis in anhydrous solvent. Omokawa H; Tanaka A; Iio M; Nishihara Y; Inoue O; Yamazaki T Radioisotopes; 1985 Sep; 34(9):480-5. PubMed ID: 4089233 [TBL] [Abstract][Full Text] [Related]
11. No-carrier-added 3-(2'-[18F]fluoroethyl)spiperone, a new dopamine receptor-binding tracer for positron emission tomography. Satyamurthy N; Bida GT; Barrio JR; Luxen A; Mazziotta JC; Huang SC; Phelps ME Int J Rad Appl Instrum B; 1986; 13(6):617-24. PubMed ID: 3494003 [TBL] [Abstract][Full Text] [Related]
12. Comparison in animal models of 18F-spiroperidol and 18F-haloperidol: potential agents for imaging the dopamine receptor. Welch MJ; Kilbourn MR; Mathias CJ; Mintun MA; Raichle ME Life Sci; 1983 Oct; 33(17):1687-93. PubMed ID: 6633162 [TBL] [Abstract][Full Text] [Related]
13. [11C]spiroperidol: synthesis, specific activity determination, and biodistribution in mice. Fowler JS; Arnett CD; Wolf AP; MacGregor RR; Norton EF; Findley AM J Nucl Med; 1982 May; 23(5):437-45. PubMed ID: 6281403 [No Abstract] [Full Text] [Related]
14. 76Br-bromospiroperidol: a new tool for quantitative in-vivo imaging of neuroleptic receptors. Mazière B; Loc'h C; Hantraye P; Guillon R; Duquesnoy N; Soussaline F; Naquet R; Comar D; Mazière M Life Sci; 1984 Sep; 35(13):1349-56. PubMed ID: 6332966 [TBL] [Abstract][Full Text] [Related]
15. Amphetamine induced decreases in (18F)-N-methylspiroperidol binding in the baboon brain using positron emission tomography (PET). Dewey SL; Logan J; Wolf AP; Brodie JD; Angrist B; Fowler JS; Volkow ND Synapse; 1991 Apr; 7(4):324-7. PubMed ID: 2042113 [No Abstract] [Full Text] [Related]
16. The synthesis of no-carrier-added DL-4-[18F]fluorodeprenyl via the nucleophilic aromatic substitution reaction. Plenevaux A; Fowler JS; Dewey SL; Wolf AP; Guillaume M Int J Rad Appl Instrum A; 1991; 42(2):121-7. PubMed ID: 1648033 [TBL] [Abstract][Full Text] [Related]
17. 3-(2'-[18F]fluoroethyl)spiperone, a potent dopamine antagonist: synthesis, structural analysis and in-vivo utilization in humans. Satyamurthy N; Barrio JR; Bida GT; Huang SC; Mazziotta JC; Phelps ME Int J Rad Appl Instrum A; 1990; 41(2):113-29. PubMed ID: 2158942 [TBL] [Abstract][Full Text] [Related]
18. Synthesis and in vivo evaluation of [18F]-N-(p-nitrobenzyl)spiperone ([18F]PNBS) in rats. Mach RH; Nowak PA; Moroney DA; Morton TE; Jackson JR; Ehrenkaufer RL Nucl Med Biol; 1993 Apr; 20(3):269-78. PubMed ID: 8485486 [TBL] [Abstract][Full Text] [Related]
19. Fluorine-18 and carbon-11 labeled amphetamine analogs--synthesis, distribution, binding characteristics in mice and rats and a PET study in monkey. Shiue CY; Shiue GG; Rysavy JA; Pleus RC; Huang H; Bai LQ; Cornish KG; Sunderland JJ; Frick MP Nucl Med Biol; 1993 Nov; 20(8):973-81. PubMed ID: 8298577 [TBL] [Abstract][Full Text] [Related]
20. Syntheses and D2 receptor affinities of derivatives of spiperone containing aliphatic halogens. Kiesewetter DO; Eckelman WC; Cohen RM; Finn RD; Larson SM Int J Rad Appl Instrum A; 1986; 37(12):1181-8. PubMed ID: 3028984 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]